| the International Standards for Neurological Classification of Spinal Cord Injury
| [0028]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0032]
[0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| CHEMICAL ABSTRACTS
| [0033]
|
| The Science and Practice of Pharmacy
| [0067]
|
| Encyclopedia of Pharmaceutical Technology
| [0067]
|
| Encyclopedia of Pharmaceutical Technology
| [0074]
|
| Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina
| [0238]
|
| Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice
| [0238]
|
| Proliferation of Schwann Cells and Regulation of Cyclin D1 Expression in an Animal Model of Charcot-Marie-Tooth Disease Type 1A
| [0238]
|
| Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner
| [0238]
|
| Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells
| [0238]
|
| Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes
| [0238]
|
| Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22
| [0238]
|
| Cyclooxygenase-2 and Colorectal Cancer Chemoprevention: The β-Catenin Connection
| [0238]
|
| A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values
| [0238]
|
| Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury
| [0238]
|
| Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22
| [0238]
|
| DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells
| [0238]
|
| The Neurotrophin Receptor p75NTR as a Positive Modulator of Myelination
| [0238]
|
| Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
| [0238]
|
| Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA
| [0238]
|
| PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats
| [0238]
|
| Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients
| [0238]
|
| Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin
| [0238]
|
| Emerging role for autophagy in the removal of aggresomes in Schwann cells
| [0238]
|
| Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model
| [0238]
|
| Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression
| [0238]
|
| The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones
| [0238]
|
| Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment
| [0238]
|
| Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol
| [0238]
|
| A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale
| [0238]
|
| Expression and functional state of the corticosteroid receptors and 11 beta-hydroxysteroid dehydrogenase type 2 in Schwann cells
| [0238]
|
| Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
| [0238]
|
| GISP: a novel brain-specific protein that promotes surface expression and function of GABA(B) receptors
| [0238]
|
| The Journal of Spinal Cord Medicine
| [0238]
|
| Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy
| [0238]
|
| Evidence for Macrophage-Mediated Myelin Disruption in an Animal Model for Charcot-Marie-Tooth Neuropathy Type 1A
| [0238]
|
| Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
| [0238]
|
| Identifying blood biomarkers for mood disorders using convergent functional genomics
| [0238]
|
| Muscle Study Group. High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A: Results of a Randomized, Double-Masked, Controlled Trial
| [0238]
|
| Induction of type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system
| [0238]
|
| Statistical Analysis with Missing Data
| [0238]
|
| On O ' Brien ' s OLS and GLS tests for multiple endpoints
| [0238]
|
| Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A
| [0238]
|
| Conditions for the Effectiveness of a Preliminary Test of Variance
| [0238]
|
| Disease progression of human SOD1 (G93A) transgenic ALS model rats
| [0238]
|
| Role of immune cells in animal models for inherited neuropathies: facts and visions
| [0238]
|
| Peripheral nerves: a target for the action of neuroactive steroids
| [0238]
|
| Rapid effects of triiodothyronine on immediate-early gene expression in Schwann cells
| [0238]
|
| Animal models of inherited neuropathies
| [0238]
|
| Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
| [0238]
|
| Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells
| [0238]
|
| Identification and functional characterization of thromboxane A2 receptors in Schwann cells
| [0238]
|
| In vivo Regulation of Extracellular Signal-Regulated Protein Kinase (ERK) and Protein Kinase B (Akt) Phosphorylation by Acute and Chronic Morphine
| [0238]
|
| Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells
| [0238]
|
| Mechanisms of disease: inherited demyelinating neuropathies-from basic to clinical research
| [0238]
|
| CMT rat'': peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22
| [0238]
|
| Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy
| [0238]
|
| Procedures for Comparing Samples with Multiple Endpoints
| [0238]
|
| GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons
| [0238]
|
| Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination
| [0238]
|
| Peripheral myelin protein 22 is expressed in human central nervous system
| [0238]
|
| Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy
| [0238]
|
| Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
| [0238]
|
| Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A
| [0238]
|
| Pharmacological induction of the heat shock response improves myelination in a neuropathic model
| [0238]
|
| Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene
| [0238]
|
| PMP22 overexpression causes dysmyelination in mice
| [0238]
|
| Synthesis of progesterone in Schwann cells: regulation by sensory neurons
| [0238]
|
| The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers
| [0238]
|
| Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
| [0238]
|
| A more realistic look at the robustness and Type II error properties of the t test to departures from population normality
| [0238]
|
| Progesterone synthesis and myelin formation in peripheral nerves
| [0238]
|
| Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
| [0238]
|
| Animal models of Charcot-Marie-Tooth disease type 1A (CMT1A)
| [0238]
|
| Reliability and validity of the CMT neuropathy score as a measure of disability
| [0238]
|
| Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases
| [0238]
|
| Disease mechanisms in inherited neuropathies
| [0238]
|
| Trembler mouse carries a point mutation in a myelin gene
| [0238]
|
| Identification of early disease progression in an ALS rat model
| [0238]
|
| The phenotypic manifestations of chromosome 17p 11.2 duplication
| [0238]
|
| Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22
| [0238]
|
| Dominant role of GABAB2 and Gbetagamma for GABAB receptor-mediated-ERK1/2/CREB pathway in cerebellar neurons
| [0238]
|
| Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element
| [0238]
|
| Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants
| [0238]
|
| Ultrastructural PMP22 expression in inherited demyelinating neuropathies
| [0238]
|
| Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BMC Med
| [0238]
|
| Nuclear triiodothyronine receptor expression is regulated by axon-Schwann cell contact
| [0238]
|
| Differential expression of triiodothyronine receptors in schwannoma and neurofibroma: role of Schwann cell-axon interaction
| [0238]
|
| Influence of molecular and chemical chaperones on protein folding
| [0238]
|
| Localisation and modulation of prostanoid receptors EP1 and EP4 in the rat chronic constriction injury model of neuropathic pain
| [0238]
|